These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 16388428

  • 41. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL, Chiu SS, Chow FK, Mak GC, Lau YL.
    Vaccine; 2007 Sep 28; 25(39-40):6837-41. PubMed ID: 17714837
    [Abstract] [Full Text] [Related]

  • 42. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
    Pletz MW, Maus U, Krug N, Welte T, Lode H.
    Int J Antimicrob Agents; 2008 Sep 28; 32(3):199-206. PubMed ID: 18378430
    [Abstract] [Full Text] [Related]

  • 43. Drug-resistant genes and serotypes of pneumococcal strains of community-acquired pneumonia among adults in Japan.
    Oishi K, Yoshimine H, Watanabe H, Watanabe K, Tanimura S, Kawakami K, Iwagaki A, Nagai H, Goto H, Kudoh S, Kuriyama T, Fukuchi Y, Matsushima T, Shimada K, Matsumoto K, Nagatake T.
    Respirology; 2006 Jul 28; 11(4):429-36. PubMed ID: 16771912
    [Abstract] [Full Text] [Related]

  • 44. Surveillance of invasive pneumococcal disease in Colombo, Sri Lanka.
    Batuwanthudawe R, Karunarathne K, Dassanayake M, de Silva S, Lalitha MK, Thomas K, Steinhoff M, Abeysinghe N.
    Clin Infect Dis; 2009 Mar 01; 48 Suppl 2():S136-40. PubMed ID: 19191609
    [Abstract] [Full Text] [Related]

  • 45. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.
    Hak E, Grobbee DE, Sanders EA, Verheij TJ, Bolkenbaas M, Huijts SM, Gruber WC, Tansey S, McDonough A, Thoma B, Patterson S, van Alphen AJ, Bonten MJ.
    Neth J Med; 2008 Oct 01; 66(9):378-83. PubMed ID: 18990781
    [Abstract] [Full Text] [Related]

  • 46. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.
    Clin Infect Dis; 2008 Aug 15; 47(4):476-84. PubMed ID: 18627249
    [Abstract] [Full Text] [Related]

  • 47. The transforming Streptococcus pneumoniae in the 21st century.
    Hsieh YC, Lee WS, Shao PL, Chang LY, Huang LM.
    Chang Gung Med J; 2008 Aug 15; 31(2):117-24. PubMed ID: 18567411
    [Abstract] [Full Text] [Related]

  • 48. 23-valent pneumococcal vaccine failure in a patient who developed pneumonia: a case report.
    Tafuri S, Martinelli D, Grimaldi A, Lopatriello A, Giorgio V, Prato R.
    New Microbiol; 2011 Oct 15; 34(4):417-20. PubMed ID: 22143817
    [Abstract] [Full Text] [Related]

  • 49. [Antimicrobial susceptibility and serotype distribution of streptococcus pneumoniae isolates in children in Tunis].
    Smaoui H, Amri J, Hajji N, Kechrid A.
    Arch Pediatr; 2009 Mar 15; 16(3):220-6. PubMed ID: 19216062
    [Abstract] [Full Text] [Related]

  • 50. Pneumococcal pneumonia including diagnosis and therapy of infection caused by penicillin-resistant strains.
    Musher DM.
    Infect Dis Clin North Am; 1991 Sep 15; 5(3):509-21. PubMed ID: 1955697
    [Abstract] [Full Text] [Related]

  • 51. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
    Vila-Córcoles A, Ochoa-Gondar O, Hospital I, Ansa X, Vilanova A, Rodríguez T, Llor C, EVAN Study Group.
    Clin Infect Dis; 2006 Oct 01; 43(7):860-8. PubMed ID: 16941367
    [Abstract] [Full Text] [Related]

  • 52. Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda.
    Kisakye A, Makumbi I, Nansera D, Lewis R, Braka F, Wobudeya E, Chaplain D, Nalumansi E, Mbabazi W, Gessner BD.
    Clin Infect Dis; 2009 Mar 01; 48 Suppl 2():S153-61. PubMed ID: 19191611
    [Abstract] [Full Text] [Related]

  • 53. Pneumococcal pneumonia and influenza: a deadly combination.
    Klugman KP, Chien YW, Madhi SA.
    Vaccine; 2009 Aug 21; 27 Suppl 3():C9-C14. PubMed ID: 19683658
    [Abstract] [Full Text] [Related]

  • 54. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.
    Vila-Corcoles A, Salsench E, Rodriguez-Blanco T, Ochoa-Gondar O, de Diego C, Valdivieso A, Hospital I, Gomez-Bertomeu F, Raga X.
    Vaccine; 2009 Mar 04; 27(10):1504-10. PubMed ID: 19171174
    [Abstract] [Full Text] [Related]

  • 55. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
    Jover F, Cuadrado JM, Andreu L, Martínez S, Cañizares R, de la Tabla VO, Martin C, Roig P, Merino J.
    Eur J Intern Med; 2008 Jan 04; 19(1):15-21. PubMed ID: 18206596
    [Abstract] [Full Text] [Related]

  • 56. Streptococcus pneumoniae bacteraemia in children.
    Myers C, Gervaix A.
    Int J Antimicrob Agents; 2007 Nov 04; 30 Suppl 1():S24-8. PubMed ID: 17707612
    [Abstract] [Full Text] [Related]

  • 57. The etiology of lobar pneumonia in the Gambia.
    Wall RA, Corrah PT, Mabey DC, Greenwood BM.
    Bull World Health Organ; 1986 Nov 04; 64(4):553-8. PubMed ID: 3490924
    [Abstract] [Full Text] [Related]

  • 58. Invasive, paediatric, vaccine strains of Streptococcus pneumoniae: are there differences in clinical characteristics?
    Trollfors B, Berg S, Backhaus E, Andersson R, Bossen Konradsen H.
    Scand J Infect Dis; 2009 Nov 04; 41(2):84-7. PubMed ID: 19012056
    [Abstract] [Full Text] [Related]

  • 59. [The preventive effect of 23-valent pneumococcal polysaccharide vaccine against drug-resistant Streptococcus pneumonia in patients with chronic respiratory disease].
    Kobayashi N, Watanuki Y, Miyazawa N, Kudo M, Inoue S, Sato T, Mishina K, Takahashi H, Kaneko T, Ishigatsubo Y.
    Nihon Kokyuki Gakkai Zasshi; 2009 Dec 04; 47(12):1063-9. PubMed ID: 20058680
    [Abstract] [Full Text] [Related]

  • 60. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003.
    Adegbola RA, Hill PC, Secka O, Ikumapayi UN, Lahai G, Greenwood BM, Corrah T.
    Trop Med Int Health; 2006 Jul 04; 11(7):1128-35. PubMed ID: 16827713
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.